Submission Guidelines

Poster Submission Deadline: 15 September 2024

All abstracts will be reviewed by the Scientific Advisory Board and applicants will be notified of the result in due course.

Successful applicants will be provided with all necessary information.

Abstract Content:

• Written in English
• Written in the third person
• Include title, name(s) and affiliation(s) of the authors
• Between 100 - 200 words
• Suitable for direct publication in the proceedings pack and on the website
• Related to the subject of the conference

Agenda Topics

• Circulating Biomarkers: cfDNA, RNA, EVs, Others
• Novel Biomarker Classes for Diagnostics Development
• Regulatory Landscape for Diagnostics in the US, circa 2024
• Technologies for Deploying Biomarkers into Novel Diagnostics Classes

Copyrights

The presenting author/person who submitted the abstract assumes full responsibility of the content of the abstract and we assume that all co-authors are aware of this content. Please note that your biography, summary and abstract may be used on this website and conference materials.